…and minimizes dyskinesias. Surgical Therapies For people with Parkinson’s who are good candidates, deep brain stimulation (DBS) or enteral suspension of carbidopa/levodopa are other options to treat Parkinson’s dyskinesia. These…
Search Results "COMPLEMENTARY THERAPIES"
…that has created unfortunately, a basis for therapies that still exist right now, the aversion or conversion therapies that are still legal in most of the states in the United…
This month’s Parkinson’s news cycle included updates on the CPDR, numerous studies on alpha-synuclein, the latest FDA approvals for Parkinson’s therapies, the most in-depth look at dance’s impact on Parkinson’s…
…therapies that still exist right now, the aversion or conversion therapies that are still legal in most of the states in the United States, only 18 states have banned it,…
…when mutated, can lead to Parkinson’s. The team hopes their findings will catalyze future research into the mitochondria recycling process and lead to new therapies. Also exploring mitochondria and Parkinson’s…
As Parkinson’s symptoms progress, increasing medications to address them can bring significant side effects, such as dyskinesia. Surgical therapies can be explored after medications are optimized and the side effects…
…focus our attention on developing therapies to preserve their function and slow the loss of these neurons,” said James Surmeier, PhD, chair of neuroscience at Northwestern’s Feinberg School of Medicine….
…optogenetic-based experimental model allows for the triggering and real-time monitoring of alpha-synuclein clustering in vivo, which may help further Parkinson’s research and therapies. The study was published in PLOS Biology….
…from 1,300 people in the Chicago Health and Aging Project, suggest that NfL may be a biomarker that can detect Parkinson’s before symptoms emerge. PARKINSON’S treatments and THERAPIES Surgeons at…
…some fields within the scope of neurology, they, these patients just because of the way they get the injury to their brain, they’re very resistant to either accepting new therapies…
…a reliable prognostic biomarker for Parkinson’s. PARKINSON’S treatments and THERAPIES New analyses of data from a large-scale, Phase 3 clinical trial showed that one year of treatment with Duopa (carbidopa/levodopa…
…as Discussion Guides that complement the Every Victory Counts manual and focus on topics including Parkinson’s symptons, medications, exercise, therapies, and more. THANK YOU TO OUR EVERY VICTORY COUNTS DISCUSSION…